Matches in Wikidata for { <http://www.wikidata.org/entity/Q85244221> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q85244221 description "article scientifique publié en 2014" @default.
- Q85244221 description "artículu científicu espublizáu en setiembre de 2014" @default.
- Q85244221 description "im September 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85244221 description "scientific article published on 02 September 2014" @default.
- Q85244221 description "wetenschappelijk artikel" @default.
- Q85244221 description "наукова стаття, опублікована у вересні 2014" @default.
- Q85244221 name "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 name "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 type Item @default.
- Q85244221 label "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 label "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 prefLabel "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 prefLabel "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 P1433 Q85244221-6CAEAD18-7D09-485E-8700-543094EF06CA @default.
- Q85244221 P1476 Q85244221-6014E4F8-E724-4C0A-9D2F-1CD79D959583 @default.
- Q85244221 P2093 Q85244221-7FB87DE2-5964-451D-9792-C96BD36A13A1 @default.
- Q85244221 P2093 Q85244221-9BAFEF08-1C1A-4BE3-8737-E2C84E33C84B @default.
- Q85244221 P304 Q85244221-1B81028D-091C-4949-A6A8-F0810E0F6271 @default.
- Q85244221 P31 Q85244221-EBBB4D5D-22A2-4F6E-954E-5D75409C8CC4 @default.
- Q85244221 P356 Q85244221-67DCEE61-25DA-477C-AFED-1D297443BD02 @default.
- Q85244221 P433 Q85244221-5CB77034-51F6-4963-A453-0DB397A3F91F @default.
- Q85244221 P478 Q85244221-36D5249E-B78F-4BF3-AB67-B1DE6C0E1A96 @default.
- Q85244221 P577 Q85244221-04A00A53-7909-4B28-A41F-141570E04ABD @default.
- Q85244221 P698 Q85244221-255F9F8F-C083-4EC6-B2B5-F8A82F233DCE @default.
- Q85244221 P921 Q85244221-A265B6E0-161C-4CB1-AD02-4675EA31C293 @default.
- Q85244221 P921 Q85244221-B73CC7F6-0DEB-4018-A354-B7282B79A2BC @default.
- Q85244221 P356 BJOPHTHALMOL-2013-304720 @default.
- Q85244221 P698 25185254 @default.
- Q85244221 P1433 Q13443571 @default.
- Q85244221 P1476 "Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion" @default.
- Q85244221 P2093 "Kanako Yasuda" @default.
- Q85244221 P2093 "Masahiko Shimura" @default.
- Q85244221 P304 "215-219" @default.
- Q85244221 P31 Q13442814 @default.
- Q85244221 P356 "10.1136/BJOPHTHALMOL-2013-304720" @default.
- Q85244221 P433 "2" @default.
- Q85244221 P478 "99" @default.
- Q85244221 P577 "2014-09-02T00:00:00Z" @default.
- Q85244221 P698 "25185254" @default.
- Q85244221 P921 Q18554884 @default.
- Q85244221 P921 Q413299 @default.